Concordance between cfDNA and tumor NGS is high for key mutations for important genes like TERT, TP53, and CTNNB1, indicating cfDNA can accurately reflect the tumor's genetic landscape. While ...

Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sample type in cancer prognosis, diagnosis, and prenatal testing 1. In parallel, the ...

This was a single-center, retrospective study with the primary objective of defining genomic alterations in circulating cfDNA along with plasma-tissue genotype agreement between NGS of matched tumor ...

Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...

A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease Enzymatic conversion–mediated ...

Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who had abnormal results for prenatal cell-free DNA (cfDNA) testing used to ...

Clinical researchers collect and measure cell-free DNA (cfDNA) in biofluids to noninvasively uncover biomarkers and mutations. Although cfDNA has become an essential tool in genetic studies, its low ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the American Journal of Transplantation (AJT) published a new ...

Dublin, Aug. 17, 2017 (GLOBE NEWSWIRE) -- The "Cell-Free DNA (cfDNA): Market Size and Share Analysis" report has been added to Research and Markets' offering. The use of cell-free DNA (cfDNA) and ...